Publicaciones en colaboración con investigadores/as de Hebrew University of Jerusalem (6)

2023

  1. Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

    Journal of Medical Genetics, Vol. 60, Núm. 12, pp. 1186-1197

2021

  1. Motixafortide and pembrolizumab combined to nanoliposomal irinotecan, fluorouracil, and folinic acid in metastatic pancreatic cancer: The COMBAT/ KEYNOTE-202 trial

    Clinical Cancer Research, Vol. 27, Núm. 18, pp. 5020-5027

2020

  1. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    Nature Medicine, Vol. 26, Núm. 6, pp. 878-885

2017

  1. Pregnancy in women with hypertrophic cardiomyopathy: Data from the European Society of Cardiology initiated Registry of Pregnancy and Cardiac disease (ROPAC)

    European Heart Journal, Vol. 38, Núm. 35, pp. 2683-2690

2015

  1. Pregnancy in Women with a Mechanical Heart Valve

    Circulation, Vol. 132, Núm. 2, pp. 132-142

2009

  1. Major lipids, apolipoproteins, and risk of vascular disease

    JAMA, Vol. 302, Núm. 18, pp. 1993-2000